Free Trial

EssilorLuxottica (ESLOY) Stock Forecast & Price Target

EssilorLuxottica logo
$82.26 +1.39 (+1.72%)
As of 10/9/2026 03:59 PM Eastern

EssilorLuxottica - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
1
Hold
3
Buy
4

Based on 8 Wall Street analysts who have issued ratings for EssilorLuxottica in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 8 analysts, 1 has given a sell rating, 3 have given a hold rating, 2 have given a buy rating, and 2 have given a strong buy rating for ESLOY.

Consensus Price Target

N/A

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for ESLOY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for EssilorLuxottica and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ESLOY Analyst Ratings Over Time

TypeCurrent Forecast
10/10/25 to 10/10/26
1 Month Ago
9/10/25 to 9/10/26
3 Months Ago
7/12/25 to 7/12/26
1 Year Ago
10/10/24 to 10/10/25
Strong Buy
2 Strong Buy rating(s)
2 Strong Buy rating(s)
2 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
3 Buy rating(s)
5 Buy rating(s)
1 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
Sell
1 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetN/AN/AN/AN/A
Forecasted UpsideN/AN/AN/AN/A
Consensus RatingModerate BuyModerate BuyModerate BuyHold

ESLOY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ESLOY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

EssilorLuxottica Stock vs. The Competition

TypeEssilorLuxotticaHealthcare CompaniesBroader Market
Consensus Rating Score
2.63
2.32
2.53
Consensus RatingModerate BuyHoldModerate Buy
Predicted UpsideN/A928.09% Upside19.60% Upside
News Sentiment Rating
Neutral News

See Recent ESLOY News
Neutral News
Positive News
Report Date
0 Results
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
9/22/2026 Reiterated RatingOutperform
9/17/2026 DowngradeStrong-Buy ➝ Strong Sell
8/18/2026
Zacks Research logo
Zacks Research
4 of 5 stars
 UpgradeStrong Sell ➝ Hold
7/14/2026 DowngradeBuy ➝ Hold
5/12/2026 Initiated CoverageHold
1/14/2026 UpgradeHold ➝ Buy
12/11/2025 Reiterated RatingBuy
11/27/2025 UpgradeHold ➝ Strong-Buy
9/9/2025 Initiated CoverageOverweight

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 06:01 PM ET.


Should I Buy EssilorLuxottica Stock? ESLOY Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, October 5, 2026. Please send any questions or comments about these EssilorLuxottica pros and cons to contact@marketbeat.com.

EssilorLuxottica
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in EssilorLuxottica Société anonyme:

  • The company recently launched a 5 million share buyback program, which signals management confidence in the stock's value and can support the share price by reducing the number of shares available for trading.
  • EssilorLuxottica Société anonyme reported a 7.2 percent increase in revenue for the second quarter of 2026, demonstrating continued top-line growth despite a broader slowdown in sales momentum.
  • The stock is currently trading at $81.46, which is near its 52-week low of $79.27, potentially offering a valuation entry point for investors who believe the recent decline is overdone.
  • The company is expanding its smart glasses portfolio with the launch of Meta Glasses priced at $299, a more affordable option that aims to capture a broader consumer market beyond the premium Ray-Ban Meta and Oakley Meta lines.
  • EssilorLuxottica Société anonyme offers a dividend yield of 2.06 percent, providing a steady income stream for investors while they wait for potential capital appreciation.

EssilorLuxottica
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in EssilorLuxottica Société anonyme for these reasons:

  • Sales growth has slowed to 8.7 percent year-over-year in the second quarter of 2026, down from 11 percent in the first quarter, indicating a deceleration in revenue momentum.
  • The stock has experienced a significant decline, hitting a 52-week low of $79.27 and trading at $81.46, which is well below its 52-week high of $186.81, reflecting substantial downside risk.
  • EssilorLuxottica Société anonyme faces governance uncertainty, including a reported $11.5 billion bid by a family heir to buy out siblings, which could create internal conflict and distract management from operational goals.
  • The company is facing increased competition in the smart glasses market, with Meta launching its own cheaper smart glasses that could erode EssilorLuxottica Société anonyme's market share in this emerging segment.
  • Analyst sentiment has turned negative, with Kepler Capital Markets downgrading the stock from "strong-buy" to "strong sell" and Zacks Research downgrading it from "hold" to "strong sell" in recent months.

ESLOY Forecast - Frequently Asked Questions

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for EssilorLuxottica in the last twelve months. There is currently 1 sell rating, 3 hold ratings, 2 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" ESLOY shares.

According to analysts, EssilorLuxottica's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

Over the previous 90 days, EssilorLuxottica's stock had 2 downgrades and 1 upgrade by analysts.

EssilorLuxottica has been rated by research analysts at Kepler Capital Markets, Royal Bank Of Canada, The Goldman Sachs Group, and Zacks Research in the past 90 days.

Analysts like EssilorLuxottica more than other "healthcare" companies. The consensus rating for EssilorLuxottica is Moderate Buy while the average consensus rating for "healthcare" companies is Hold. Learn more on how ESLOY compares to other companies.


MarketBeat monitors more than a dozen sources for EssilorLuxottica analyst ratings, with the most recent rating issued on 9/22/2026.
From Our Partners